Mitochondrial composition and function under the control of hypoxia.
about
Increased IL-6 expression on THP-1 by IL-34 stimulation up-regulated rheumatoid arthritis Th17 cells.Maintenance of redox homeostasis by hypoxia-inducible factors.Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways.Non-electron transfer chain mitochondrial defects differently regulate HIF-1α degradation and transcription.Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission.Effects of melatonin on fatty liver disease: The role of NR4A1/DNA-PKcs/p53 pathway, mitochondrial fission, and mitophagy.Melatonin suppresses platelet activation and function against cardiac ischemia/reperfusion injury via PPARγ/FUNDC1/mitophagy pathways.Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy.Mitochonic acid 5 activates the MAPK-ERK-yap signaling pathways to protect mouse microglial BV-2 cells against TNFα-induced apoptosis via increased Bnip3-related mitophagy.miR-125a induces apoptosis, metabolism disorder and migrationimpairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission.ER–Mitochondria Microdomains in Cardiac Ischemia–Reperfusion Injury: A Fresh Perspective.Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathwaysTMEM126B deficiency reduces mitochondrial SDH oxidation by LPS, attenuating HIF-1α stabilization and IL-1β expressionTNFα promotes glioblastoma A172 cell mitochondrial apoptosis via augmenting mitochondrial fission and repression of MAPK–ERK–YAP signaling pathwaysTAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathwayIL-2 augments the sorafenib-induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
P2860
Q38694818-D2FF1557-EE0D-4AB6-9E4E-F760B21851DAQ39380299-E727D61E-7E38-4A90-AA38-086B889FDE2CQ41602780-2DAA3FAC-E933-4415-8DF7-4762A929947CQ42250932-68336CCF-90C1-4DA0-BDA6-91D65D8D4087Q47201817-A09E3F93-EED6-48CE-98AD-E49CD9BD7DBAQ47752889-C10778AB-D4EC-452A-9F54-9DE81A0A767DQ47819663-998A94EA-E293-44AA-9351-977D55F4E7BDQ50047535-83CA9100-3B4F-4EC5-B1C7-0493F9D16C90Q52595172-04B71812-8491-44BB-B955-BE8C69084445Q55294362-F1AA312C-5CD6-4787-B644-FCACBA594F90Q55378990-8E67F95D-74D6-4B54-AF7D-E2AFDB764B27Q58120151-A95872D3-3A16-4505-B464-0ADF964C755EQ58121148-8C930775-E6C2-458D-A77A-E15A1A55F088Q58698788-AFEB6935-2709-4412-A202-1B4A90DD6EBDQ58782559-95D95477-98FA-42D0-98ED-7BD68CEC3A31Q59136123-AFA20A67-0C53-473D-9DA7-44FB2AA80CAE
P2860
Mitochondrial composition and function under the control of hypoxia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitochondrial composition and function under the control of hypoxia.
@en
Mitochondrial composition and function under the control of hypoxia.
@nl
type
label
Mitochondrial composition and function under the control of hypoxia.
@en
Mitochondrial composition and function under the control of hypoxia.
@nl
prefLabel
Mitochondrial composition and function under the control of hypoxia.
@en
Mitochondrial composition and function under the control of hypoxia.
@nl
P2860
P1433
P1476
Mitochondrial composition and function under the control of hypoxia.
@en
P2093
Dominik C Fuhrmann
P2860
P304
P356
10.1016/J.REDOX.2017.02.012
P5008
P577
2017-02-24T00:00:00Z
2017-08-01T00:00:00Z